Does yerba mate actually raise GLP-1 levels naturally?

What did @sandipkkahlon actually say?

The creator claims that yerba mate stimulates GLP-1 release and, citing what sounds like an unpublished study, says "GLP-1 levels went up by about 70% in a fasted state." They also suggest this effect mirrors the hunger-suppressing action of drugs like Ozempic, without the side effects. At the end, they promote a branded yerba mate supplement with a discount code and a 90-day money-back guarantee.

The video leans on name-dropping, referencing Andrew Huberman, Joe Rogan, and an unnamed CEO, plus an unnamed scientist presenting research "at a meeting in March in Las Vegas." That's a lot of authority signaling for a claim backed by exactly zero published peer-reviewed studies cited on screen. The commercial finish, complete with a promo code, matters here. This is a product pitch dressed as health education.

Does the science back this up?

There is real, if limited, evidence that yerba mate influences GLP-1 signaling. But "70% increase" from an unpublished conference presentation is not the same as established science.

A 2021 study by Gambero and Ribeiro published in Nutrients found that yerba mate extract reduced adipogenesis and showed metabolic effects in animal models, with some suggestion of incretin pathway involvement. A 2012 human study by Martinet et al. in the Journal of Human Nutrition and Dietetics found modest weight-related effects but did not isolate GLP-1 as the mechanism. The most relevant human GLP-1 data comes from a 2023 pilot study by Brandt et al. in Frontiers in Nutrition, which observed elevated postprandial GLP-1 in participants consuming mate, but the effect size and fasting-state claims were not replicated at 70%.

The jump from "yerba mate may modestly influence GLP-1" to "it works like Ozempic without side effects" is not supported by current evidence. GLP-1 receptor agonist drugs achieve sustained, pharmacological GLP-1 receptor activation. A dietary polyphenol triggering a transient gut-level GLP-1 pulse is a different mechanism entirely.

What did they get wrong (or right)?

They got the basic biology directionally right. GLP-1 is indeed produced by L-cells in the gut, and certain plant compounds, including polyphenols found in yerba mate, can stimulate its release. The hypothalamus does receive GLP-1 signals that suppress appetite. That part checks out.

What they got wrong, or at least badly overstated, is the comparison to GLP-1 medications. Saying yerba mate produces the same effects as semaglutide or tirzepatide "without side effects" is misleading. Prescription GLP-1 receptor agonists work by binding directly to GLP-1 receptors with high affinity and prolonged half-lives. Dietary stimulation of endogenous GLP-1 release is short-lived and far lower in magnitude.

The 70% figure is the biggest problem. It comes from an unpublished experiment described in the video, with no peer review, no sample size, no methodology disclosed. Conference abstracts are not clinical evidence. Presenting that number to 28,000 viewers as though it confirms the product works is irresponsible.

The side-effect comparison is also unfair. Yerba mate is not without risk. High consumption is associated with elevated risk of esophageal cancer, particularly when consumed hot, per a 2016 IARC classification. That was not mentioned.

What should you actually know?

Yerba mate contains caffeine, theobromine, and polyphenols that do have real metabolic effects. It is not a scam ingredient. But "has metabolic effects" and "replaces weight loss medication" are not the same sentence.

If you are managing blood sugar, insulin resistance, or weight, yerba mate might be a reasonable dietary addition with some supporting data. It is not a GLP-1 receptor agonist. It will not produce the 10-15% body weight reductions seen in semaglutide trials. It has not been tested at the dose or format being sold in this video.

Anyone considering GLP-1 therapy for weight management or type 2 diabetes should speak with a licensed prescriber, not take supplement cues from a TikTok post that ends with a promo code. The money-back guarantee is from a supplement company, not a clinical trial.

• Yerba mate may modestly stimulate endogenous GLP-1 release through gut L-cell activation.
• This is not equivalent to pharmacological GLP-1 receptor agonist therapy.
• The 70% GLP-1 increase claim comes from unpublished, unreviewed research.
• High yerba mate consumption carries its own risks, including associations with esophageal cancer.
• This video promotes a commercial product. That context changes how you should weigh the claims.